Hirschsprung disease (HSCR) is a multigenic condition with variable presentation. Most commonly, it presents in the neonatal period as a functional intestinal obstruction secondary to failure of caudal migration of the enteric nervous system. Classically, this manifests as dilated proximal bowel and constricted distal bowel with absent ganglia and hypertrophic nerve trunks. When recognized early, medical and surgical therapies can be instituted to minimize associated morbidity and mortality. This article reviews current understanding of the etiology of HSCR, its multigenic associations, the historical evolution of HSCR diagnosis and treatment, and current HSCR therapies.
FrykmanPKShortSS. Hirschsprung-associated enterocolitis: prevention and therapy. Semin Pediatr Surg. 2012;21:328-335.
7.
LevinDNMarconMARintalaRJJacobsonDLangerJC. Inflammatory bowel disease manifesting after surgical treatment for Hirschsprung disease. J Pediatr Gastroenterol Nutr. 2012;55:272-277.
8.
Butler TjadenNETrainorPA. The developmental etiology and pathogenesis of Hirschsprung disease. Transl Res. 2013;162:1-15.
9.
NishiyamaCUesakaTManabeT. Trans-mesenteric neural crest cells are the principal source of the colonic enteric nervous system. Nat Neurosci. 2012;15:1211-1218.
10.
JannotASPeletAHenrion-CaudeA. Chromosome 21 scan in Down syndrome reveals DSCAM as a predisposing locus in Hirschsprung disease. PLoS One. 2013;8(5):e62519.
11.
WatersAMBealesPL. Bardet-Biedl syndrome. In: PagonRABirdTDDolanCRStephensKAdamMP, eds. GeneReviews. Seattle, WA: University of Washington; 1993-2013.
12.
TobinJLBealesPL. The nonmotile ciliopathies. Genet Med. 2009;11:386-402.
de PontualLMathieuYGolzioC. Mutational, functional, and expression studies of the TCF4 gene in Pitt-Hopkins syndrome. Hum Mutat. 2009;30:669-676.
15.
AmielJSproat-EmisonEGarcia-BarceloM. Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet. 2008;45:1-14.
16.
EmisonESGarcia-BarceloMGriceEA. Differential contributions of rare and common, coding and noncoding Ret mutations to multifactorial Hirschsprung disease liability. Am J Hum Genet. 2010;87:60-74.
17.
IvanchukSMMyersSMEngCMulliganLM. De novo mutation of GDNF, ligand for the RET/GDNFR-alpha receptor complex, in Hirschsprung disease. Hum Mol Genet. 1996;5:2023-2026.
18.
DorayBSalomonRAmielJ. Mutation of the RET ligand, neurturin, supports multigenic inheritance in Hirschsprung disease. Hum Mol Genet. 1998;7:1449-1452.
19.
Runeberg-RoosPSaarmaM. Neurotrophic factor receptor RET: structure, cell biology, and inherited diseases. Ann Med. 2007;39:572-580.
20.
InoueKShimotakeTIwaiN. Mutational analysis of RET/GDNF/NTN genes in children with total colonic aganglionosis with small bowel involvement. Am J Med Genet. 2000;93:278-284.
21.
ShimotakeTGoSInoueKTomiyamaHIwaiN. A homozygous missense mutation in the tyrosine E kinase domain of the RET proto-oncogene in an infant with total intestinal aganglionosis. Am J Gastroenterol. 2001;96:1286-1291.
22.
Nunez-TorresRFernandezRMAcostaMJ. Comprehensive analysis of RET common and rare variants in a series of Spanish Hirschsprung patients confirms a synergistic effect of both kinds of events. BMC Med Genet. 2011;12:138.
23.
SchuchardtAD’AgatiVLarsson-BlombergLCostantiniFPachnisV. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature. 1994;367:380-383.
24.
Plaza-MenachoIBurzynskiGMde GrootJWEggenBJHofstraRM. Current concepts in RET-related genetics, signaling and therapeutics. Trends Genet. 2006;22:627-636.
25.
BatourinaEChoiCParagasN. Distal ureter morphogenesis depends on epithelial cell remodeling mediated by vitamin A and Ret. Nat Genet. 2002;32:109-115.
26.
HofstraRMElfferichPOsingaJ. Hirschsprung disease and L1CAM: is the disturbed sex ratio caused by L1CAM mutations?J Med Genet. 2002;39(3):E11.
27.
ShinMKLevorseJMIngramRSTilghmanSM. The temporal requirement for endothelin receptor-B signalling during neural crest development. Nature. 1999;402:496-501.
28.
ZhuLLeeHOJordanCSCantrellVASouthard-SmithEMShinMK. Spatiotemporal regulation of endothelin receptor-B by SOX10 in neural crest-derived enteric neuron precursors. Nat Genet. 2004;36:732-737.
29.
McCallionASChakravartiA. EDNRB/EDN3 and Hirschsprung disease type II. Pigment Cell Res. 2001;14:161-169.
30.
ZweierCTempleIKBeemerF. Characterisation of deletions of the ZFHX1B region and genotype-phenotype analysis in Mowat-Wilson syndrome. J Med Genet. 2003;40:601-605.
31.
Cerruti MainardiPPastoreGZweierCRauchA. Mowat-Wilson syndrome and mutation in the zinc finger homeo box 1B gene: a well defined clinical entity. J Med Genet. 2004;41:E16.
32.
KwonMJLeeGHLeeMK. PHOX2B mutations in patients with Ondine-Hirschsprung disease and a review of the literature. Eur J Pediatr. 2011;170:1267-1271.
33.
MooreSW. The contribution of associated congenital anomalies in understanding Hirschsprung’s disease. Pediatr Surg Int. 2006;22:305-315.
34.
ShaharEShinawiM. Neurocristopathies presenting with neurologic abnormalities associated with Hirschsprung’s disease. Pediatr Neurol. 2003;28:385-391.
35.
BillAHChapmanND. The enterocolitis of Hirschsprung’s disease: its natural history and treatment. Am J Surg. 1962;103:70-74.
36.
PastorACOsmanFTeitelbaumDHCatyMGLangerJC. Development of a standardized definition for Hirschsprung’s-associated enterocolitis: a Delphi analysis. J Pediatr Surg. 2009;44:251-256.
37.
AustinKM. The pathogenesis of Hirschsprung’s disease-associated enterocolitis. Semin Pediatr Surg. 2012;21:319-327.
38.
Southard-SmithEMAngristMEllisonJS. The Sox10(Dom) mouse: modeling the genetic variation of Waardenburg-Shah (WS4) syndrome. Genome Res. 1999;9:215-225.
39.
PuriPGosemannJH. Variants of Hirschsprung disease. Semin Pediatr Surg. 2012;21:310-318.
40.
van der DoefHPKokkeFTvan der EntCKHouwenRH. Intestinal obstruction syndromes in cystic fibrosis: meconium ileus, distal intestinal obstruction syndrome, and constipation. Curr Gastroenterol Rep. 2011;13:265-270.
41.
CarlyleBEBorowitzDSGlickPL. A review of pathophysiology and management of fetuses and neonates with meconium ileus for the pediatric surgeon. J Pediatr Surg. 2012;47:772-781.
42.
PratapAGuptaDKTiwariA. Application of a plain abdominal radiograph transition zone (PARTZ) in Hirschsprung’s disease. BMC Pediatr. 2007;7:5.
43.
GarciaRArcementCHormazaL. Use of the recto-sigmoid index to diagnose Hirschsprung’s disease. Clin Pediatr (Phila). 2007;46:59-63.
44.
Vult von SteyernKWingrenPWiklundMStenströmPArnbjörnssonE. Visualisation of the rectoanal inhibitory reflex with a modified contrast enema in children with suspected Hirschsprung disease. Pediatric Radiol. 2013;43:950-957.
45.
SwensonOFisherJHMacmahonHE. Rectal biopsy as an aid in the diagnosis of Hirschsprung’s disease. N Engl J Med. 1955;253:632-635.
46.
DobbinsWO3rdBillAHJr. Diagnosis of Hirschsprung’s disease excluded by rectal suction biopsy. N Engl J Med. 1965;272:990-993.
47.
HollandSKRamalingamPPodolskyRHReid-NicholsonMDLeeJR. Calretinin immunostaining as an adjunct in the diagnosis of Hirschsprung disease. Ann Diagn Pathol. 2011;15:323-328.
48.
Guinard-SamuelVBonnardADe LagausieP. Calretinin immunohistochemistry: a simple and efficient tool to diagnose Hirschsprung disease. Mod Pathol. 2009;22:1379-1384.
49.
DiamondIRCasadiegoGTraubiciJLangerJCWalesPW. The contrast enema for Hirschsprung disease: predictors of a false-positive result. J Pediat Surg. 2007;42:792-795.
50.
GravesS. Congenital idiopathic dilatation of the colon or Hirschsprung’s disease. Ann Surg. 1918;67:734-737.
51.
JuddESAdsonAW. Lumbar sympathetic ganglionectomy and ramisectomy for congenital idiopathic dilatation of the colon. Ann Surg. 1928;88:479-498.
52.
TelfordEDHaxtonHA. Congenital megacolon: results of treatment by spinal anaesthesia. BMJ. 1948;1(4556):827.
53.
SwensonORheinlanderHFDiamondI. Hirschsprung’s disease: a new concept of the etiology. N Engl J Med. 1949;241:551-556.
54.
FullertonA. Congenital idiopathic dilatation of the colon treated by stretching of the pelvi-rectal sphincter. BMJ. 1927;1(3459):753-754.
55.
YeazellLABellHG. Results of medical and surgical management in ten cases of congenital megacolon. Calif Med. 1949;70:398-400.
56.
SwensonONeuhauserEBPickettLK. New concepts of the etiology, diagnosis and treatment of congenital megacolon (Hirschsprung’s disease). Pediatrics. 1949;4:201-209.
57.
YanceyAGCromartieJJrFordJRNicholsRRJrSavilleAJr. A modification of the Swenson technique for congenital megacolon. J Natl Med Assoc. 1952;44:356.
58.
SoaveF. Hirschsprung’s disease: a new surgical technique. Arch Dis Child. 1964;39:116-124.
59.
DuhamelB. A new operation for the treatment of Hirschsprung’s disease. Arch Dis Child. 1960;35:38-39.
60.
MartinLWAltemeierWA. Clinical experience with a new operation (modified Duhamel procedure) for Hirschsprung’s disease. Ann Surg. 1962;156:678-681.
61.
NiedzielskiJ. Posterior sagittal abdominoperineal pull-through: a new approach to definitive treatment of Hirschsprung’s disease—initial experience. J Pediatr Surg. 1999;34:572-576.
62.
ZganjerMCigitICarAVisnjićSButkovićD. Hirschsprung’s disease and Rehbein’s procedure—our results in the last 30 years. Coll Antropol. 2006;30:905-907.
63.
WesterTZetterlindLFredinKOlsenL. Postoperative obstructive symptoms are common after Rehbein’s procedure for Hirschsprung’s disease. Eur J Pediatr Surg. 2006;16:100-103.
64.
LangerJC. Laparoscopic and transanal pull-through for Hirschsprung disease. Semin Pediatr Surg. 2012;21:283-290.
65.
GeorgesonKEFuenferMMHardinWD. Primary laparoscopic pull-through for Hirschsprung’s disease in infants and children. J Pediatr Surg. 1995;30:1017-1021.
66.
ChenYNahSALaksmiNK. Transanal endorectal pull-through versus transabdominal approach for Hirschsprung’s disease: a systematic review and meta-analysis. J Pediatr Surg. 2013;48:642-651.
67.
RintalaRJPakarinenMP. Long-term outcomes of Hirschsprung’s disease. Semin Pediatr Surg. 2012;21:336-343.
68.
JarviKLaitakariEMKoivusaloARintalaRJPakarinenMP. Bowel function and gastrointestinal quality of life among adults operated for Hirschsprung disease during childhood: a population-based study. Ann Surg. 2010;252:977-981.
69.
EscobarMAGrosfeldJLWestKW. Long-term outcomes in total colonic aganglionosis: a 32-year experience. J Pediatr Surg. 2005;40:955-961.
70.
Catto-SmithAGTrajanovskaMTaylorRG. Long-term continence in patients with Hirschsprung’s disease and Down syndrome. J Gastroenterol Hepatol. 2006;21:748-753.
71.
MenezesMPuriP. Long-term clinical outcome in patients with Hirschsprung’s disease and associated Down’s syndrome. J Pediatr Surg. 2005;40:810-812.
72.
HeikkinenMRintalaRLuukkonenP. Long-term anal sphincter performance after surgery for Hirschsprung’s disease. J Pediatr Surg. 1997;32:1443-1446.
73.
ZhangSCBaiYZWangWWangWL. Long-term outcome, colonic motility, and sphincter performance after Swenson’s procedure for Hirschsprung’s disease: a single-center 2-decade experience with 346 cases. Am J Surg. 2007;194:40-47.
74.
ZakariaOM. Bowel function and fecal continence after Soave’s trans-anal endorectal pull-through for Hirschsprung’s disease: a local experience. Updates Surg. 2012;64:113-118.
75.
BoemersTMBaxNMvan GoolJD. The effect of rectosigmoidectomy and Duhamel-type pull-through procedure on lower urinary tract function in children with Hirschsprung’s disease. J Pediatr Surg. 2001;36:453-456.
76.
MooreSWAlbertynRCywesS. Clinical outcome and long-term quality of life after surgical correction of Hirschsprung’s disease. J Pediatr Surg. 1996;31:1496-1502.
77.
ElhalabyEATeitelbaumDHCoranAGHeidelbergerKP. Enterocolitis associated with Hirschsprung’s disease: a clinical histopathological correlative study. J Pediatr Surg. 1995;30:1023-1026.
78.
HuangEYTolleyEABlakelyMLLanghamMR. Changes in hospital utilization and management of Hirschsprung disease: analysis using the kids’ inpatient database. Ann Surg. 2013;257:371-375.
